rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2005-9-12
|
pubmed:abstractText |
This study examined the clinical relevance of fine-particle mass (FPM) delivered from metered dose inhalers (MDIs) to bronchodilatation and bronchoprotection against methacholine challenge by comparing a marketed chlorofluorocarbon (CFC) formulation of salmeterol with an investigational hydrofluoroalkane (HFA)formulation.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0149-2918
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1004-12
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16154479-Adult,
pubmed-meshheading:16154479-Albuterol,
pubmed-meshheading:16154479-Asthma,
pubmed-meshheading:16154479-Bronchial Provocation Tests,
pubmed-meshheading:16154479-Bronchoconstriction,
pubmed-meshheading:16154479-Bronchoconstrictor Agents,
pubmed-meshheading:16154479-Bronchodilator Agents,
pubmed-meshheading:16154479-Cross-Over Studies,
pubmed-meshheading:16154479-Double-Blind Method,
pubmed-meshheading:16154479-Female,
pubmed-meshheading:16154479-Humans,
pubmed-meshheading:16154479-Male,
pubmed-meshheading:16154479-Metered Dose Inhalers,
pubmed-meshheading:16154479-Methacholine Chloride,
pubmed-meshheading:16154479-Middle Aged,
pubmed-meshheading:16154479-Particle Size
|
pubmed:year |
2005
|
pubmed:articleTitle |
The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
|
pubmed:affiliation |
Medicines Evaluation Unit, North West Lung Centre, Wythenshawe Hospital, Manchester, UK.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|